Jizhang Zhu - Search Results

Year	Number of Results
2014	4
2015	4
2016	5
2017	6
2018	12
2019	13
2020	17
2021	15
2022	15
2023	11
2024	6

1

Wang S, Zhang Y. Wang S, et al. J Hematol Oncol. 2020 Aug 24;13(1):116. doi: 10.1186/s13045-020-00950-x. J Hematol Oncol. 2020. PMID: 32831115 Free PMC article.

2

Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.

Yang L, Li A, Wang Y, Zhang Y. Yang L, et al. Signal Transduct Target Ther. 2023 Jan 16;8(1):35. doi: 10.1038/s41392-022-01304-4. Signal Transduct Target Ther. 2023. PMID: 36646684 Free PMC article. Review.

3

Immunosenescence: molecular mechanisms and diseases.

Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X. Liu Z, et al. Signal Transduct Target Ther. 2023 May 13;8(1):200. doi: 10.1038/s41392-023-01451-2. Signal Transduct Target Ther. 2023. PMID: 37179335 Free PMC article. Review.

4

Immunosenescence: a key player in cancer development.

Lian J, Yue Y, Yu W, Zhang Y. Lian J, et al. J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z. J Hematol Oncol. 2020. PMID: 33168037 Free PMC article. Review.

5

Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.

Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y. Yu W, et al. J Hematol Oncol. 2021 Nov 6;14(1):187. doi: 10.1186/s13045-021-01200-4. J Hematol Oncol. 2021. PMID: 34742349 Free PMC article. Review.

6

Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells.

Qin G, Liu S, Liu J, Hu H, Yang L, Zhao Q, Li C, Zhang B, Zhang Y. Qin G, et al. Signal Transduct Target Ther. 2023 Apr 28;8(1):164. doi: 10.1038/s41392-023-01388-6. Signal Transduct Target Ther. 2023. PMID: 37105980 Free PMC article.

7

Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.

Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, Liu S, Li A, He Z, Liu J, Sun Z, Yuan W, Zhang Y. Wang D, et al. J Immunother Cancer. 2019 Aug 8;7(1):215. doi: 10.1186/s40425-019-0701-2. J Immunother Cancer. 2019. PMID: 31395078 Free PMC article.

8

Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1.

Zhou L, Wu D, Zhou Y, Wang D, Fu H, Huang Q, Qin G, Chen J, Lv J, Lai S, Zhang H, Tang K, Ma J, Fiskesund R, Zhang Y, Zhang X, Huang B. Zhou L, et al. Nat Immunol. 2023 Dec;24(12):2042-2052. doi: 10.1038/s41590-023-01662-3. Epub 2023 Nov 2. Nat Immunol. 2023. PMID: 37919525 Free PMC article.

9

COVID-19: immunopathogenesis and Immunotherapeutics.

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y. Yang L, et al. Signal Transduct Target Ther. 2020 Jul 25;5(1):128. doi: 10.1038/s41392-020-00243-2. Signal Transduct Target Ther. 2020. PMID: 32712629 Free PMC article. Review.

10

Myeloid cells in COVID-19 microenvironment.

Qin G, Liu S, Yang L, Yu W, Zhang Y. Qin G, et al. Signal Transduct Target Ther. 2021 Oct 27;6(1):372. doi: 10.1038/s41392-021-00792-0. Signal Transduct Target Ther. 2021. PMID: 34707085 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year